Netherlands · 
What does BioGeneration Ventures invest in?
BioGeneration Ventures invests most often at Series A and Series B (83% of the rounds on record), in sectors such as Big Data, Market Research and Life Science.
BioGeneration Ventures highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series A and Series B: 83% of its rounds
- 03
Sole investor in 1 rounds, median undisclosed
- 04
1 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Pre-seedSeedSeries ASeries BGrowth
- Sectors
- Big DataMarket ResearchLife Science
- Based in
- Naarden, Netherlands
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first15 appearances
- 2026
1 round
- Oct
- 2025
2 rounds
- Dec
- May
- 2024
2 rounds
- Dec
- Jul
- 2019
1 round
- May
- 2017
1 round
- Jan
- 2014
2 rounds
- Dec
- Feb
- 2013
1 round
- Mar
- 2012
1 round
- Nov
- 2010
1 round
- Feb
- 2009
3 rounds
- Dec
- Sept
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 13 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$520Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Biogeneration III Services B.v.
- SEC number
- CRD 327422
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Lanthio PharmaBought by MorphoSys$23MMay 2015
An exit counts when it came after the firm's first round in the company. From historical deal records.